Alexandria Real Estate Equities
ARE
#2319
Rank
S$10.18 B
Marketcap
S$58.94
Share price
-2.38%
Change (1 day)
-56.29%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Total debt

Total debt on the balance sheet as of September 2025 : S$18.08 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's total debt is S$18.08 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Alexandria Real Estate Equities - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$17.33 B12.18%
2023-12-31S$15.45 B9.07%
2022-12-31S$14.16 B13.56%
2021-12-31S$12.47 B19.21%
2020-12-31S$10.46 B10.1%
2019-12-31S$9.50 B26.99%
2018-12-31S$7.48 B17.44%
2017-12-31S$6.37 B5.75%
2016-12-31S$6.02 B8.25%
2015-12-31S$5.56 B14.54%
2014-12-31S$4.86 B25.33%
2013-12-31S$3.87 B-0.33%
2012-12-31S$3.89 B8.11%
2011-12-31S$3.59 B8.13%
2010-12-31S$3.32 B-13.68%
2009-12-31S$3.85 B-8.22%
2008-12-31S$4.20 B4.74%
2007-12-31S$4.01 B29.21%
2006-12-31S$3.10 B32.57%
2005-12-31S$2.34 B20.95%
2004-12-31S$1.93 B60.75%
2003-12-31S$1.20 B12.91%
2002-12-31S$1.06 B0.55%
2001-12-31S$1.06 B41.96%
2000-12-31S$0.74 B28.08%
1999-12-31S$0.58 B14.1%
1998-12-31S$0.51 B328.49%
1997-12-31S$0.11 B-24.65%
1996-12-31S$0.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
S$78.85 B 336.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$32.32 B 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.08 B 204.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.33 B-81.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$66.14 B 265.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$70.73 B 291.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.69 B-90.62%๐Ÿ‡บ๐Ÿ‡ธ USA